BUSULFAN vs TEMODAR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. BUSULFAN and TEMODAR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BUSULFAN	TEMODAR
Rating	72/100	70/100
Pharmacy pays	—	~$148.82 /30
Type	RX	RX
Active ingredient	BUSULFAN	TEMOZOLOMIDE
Manufacturer	Actavis	Merck Sharp Dohme
Dosage forms	Injectable, Solution	Capsule, Injectable
Drug class	Alkylating Drug	Alkylating Drug
Boxed warning	None	None
Treats	Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis	Glioblastoma, Melanoma

busulfan temodar

Rating

72/100

70/100

Pharmacy pays

—

~$148.82 /30

Type

Active ingredient

BUSULFAN

TEMOZOLOMIDE

Manufacturer

Actavis

Merck Sharp Dohme

Dosage forms

Injectable, Solution

Capsule, Injectable

Drug class

Alkylating Drug

Boxed warning

None

Treats

Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis

Glioblastoma, Melanoma

Frequently asked questions

Which is better-rated, Busulfan or Temodar?

By our independent rating, Busulfan scores higher — 3.6 vs 3.5 out of 5 for Temodar. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Busulfan and Temodar?

Busulfan contains Busulfan, while Temodar contains Temozolomide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.